GGrantIndex
← Leaderboards

Richard P. Phipps

University Of Rochester

$12,624,990
Attributed
$14,941,779
Total exposure
18
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200517
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$14,941,779 · 18

By mechanism

R01$11,781,673 · 10
R21$1,918,090 · 5
RC1$1,000,000 · 1
R03$154,000 · 1
P30$88,016 · 1

Top collaborators

Most similar at University Of Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Inflammation

Research focus

InflammationCellsFibroblastsCytokineInflammatoryIn VitroTissuesProstaglandinsProductionPublishingTranscription FactorLigandsAffectIn VivoMediator Of Activation ProteinSignal TransductionAnti-InflammatoryFoundationsAnti-Inflammatory AgentsMediatingPathway InteractionsLeadLipid MediatorProperty

Grant awards (50)

Thy1 expression, adpogenesis, inflammation and orbital remodeling mechanisms in Thyroid Eye Disease$384,583
R01 · FY2017 · EY · contact PI
Dysregulation of common metabolic and transcriptional pathways in heart and lung fibrosis$537,250
R01 · FY2016 · HL · contact PI
Novel therapies for cigarette smoke induced lung injury$389,385
R01 · FY2016 · HL
Aryl Hydrocarbon Receptor Ligands and Thyroid Eye Disease$345,375
R01 · FY2016 · EY · contact PI
Novel therapies for cigarette smoke induced lung injury$383,515
R01 · FY2015 · HL
Aryl Hydrocarbon Receptor Ligands and Thyroid Eye Disease$338,467
R01 · FY2015 · EY · contact PI
Localized Vulvodynia Pathogenesis: Fibroblast, Yeast, and Melanocortin$308,806
R01 · FY2015 · HD
Platelet dysfunction due to HIV in ART treated Smokers$230,250
R21 · FY2015 · HL · contact PI
Novel therapies for cigarette smoke induced lung injury$402,612
R01 · FY2014 · HL
Aryl Hydrocarbon Receptor Ligands and Thyroid Eye Disease$338,468
R01 · FY2014 · EY · contact PI
Localized Vulvodynia Pathogenesis: Fibroblast, Yeast, and Melanocortin$307,857
R01 · FY2014 · HD
Environmental obesogens reduce Thy1 expression and promote obesity$227,948
R21 · FY2014 · ES · contact PI
Naturally Occurring Lipid Mediators Enhance Antibody Production$191,875
R21 · FY2014 · AI · contact PI
Aryl Hydrocarbon Receptor Ligands and Thyroid Eye Disease$345,375
R01 · FY2013 · EY · contact PI
Localized Vulvodynia Pathogenesis: Fibroblast, Yeast, and Melanocortin$300,572
R01 · FY2013 · HD
Naturally Occurring Lipid Mediators Enhance Antibody Production$230,250
R21 · FY2013 · AI · contact PI
Environmental obesogens reduce Thy1 expression and promote obesity$191,875
R21 · FY2013 · ES · contact PI
Identification and Significance of Biologic Mediators in Red Cell Concentrates$382,388
R01 · FY2012 · HL
Localized Vulvodynia Pathogenesis: Fibroblast, Yeast, and Melanocortin$313,130
R01 · FY2012 · HD
Identification and Significance of Biologic Mediators in Red Cell Concentrates$386,250
R01 · FY2011 · HL
Microparticles as Messengers of Communication Between Blood and Vascular Cells$500,000
RC1 · FY2010 · HL · contact PI
Identification and Significance of Biologic Mediators in Red Cell Concentrates$383,438
R01 · FY2010 · HL
Role of T cells and PPARgamma in Graves' orbital fibroblast adipogenesis$373,777
R01 · FY2010 · EY · contact PI
Microparticles as Messengers of Communication Between Blood and Vascular Cells$500,000
RC1 · FY2009 · HL · contact PI
Identification and Significance of Biologic Mediators in Red Cell Concentrates$384,375
R01 · FY2009 · HL
Regulation of Immunity by Prostaglandins$354,752
R01 · FY2009 · DE · contact PI
Role of T cells and PPARgamma in Graves' orbital fibroblast adipogenesis$224,301
R01 · FY2009 · EY · contact PI
Role of T cells and PPARgamma in Graves' orbital fibroblast adipogenesis$153,834
R01 · FY2009 · EY · contact PI
Pathways to Fibrosis$77,000
R03 · FY2009 · HL
Regulation of Immunity by Prostaglandins$354,752
R01 · FY2008 · DE · contact PI
Role of T cells and PPARgamma in Graves' orbital fibroblast adipogenesis$219,815
R01 · FY2008 · EY · contact PI
Role of cyclooxygenase-2 in antibody responses to vaccination$188,843
R21 · FY2008 · AI · contact PI
Pathways to Fibrosis$77,000
R03 · FY2008 · HL
Regulation of Immunity by Prostaglandins$358,697
R01 · FY2007 · DE · contact PI
Platelet Activation and Inflammatory Mediators$295,832
R01 · FY2007 · HL · contact PI
Role of cyclooxygenase-2 in antibody responses to vaccination$231,000
R21 · FY2007 · AI · contact PI
Role of T cells and PPARgamma in Graves' orbital fibroblast adipogenesis$224,301
R01 · FY2007 · EY · contact PI
Normal and Type-2 Diabetic Platelet Proteomics and Storage for Transfusion$180,191
R21 · FY2007 · HL · contact PI
Regulation of Immunity by Prostaglandins$332,469
R01 · FY2006 · DE · contact PI
Platelet Activation and Inflammatory Mediators$304,668
R01 · FY2006 · HL · contact PI
Normal and Type-2 Diabetic Platelet Proteomics Storage$245,858
R21 · FY2006 · HL · contact PI
Role of T cells and PPARgamma in Graves' orbital fibroblast adipogenesis$231,000
R01 · FY2006 · EY · contact PI
Regulation of Immunity by Prostaglandins$340,470
R01 · FY2005 · DE
Platelet Activation and Inflammatory Mediators$312,000
R01 · FY2005 · HL
Platelet Activation and Inflammatory Mediators$312,000
R01 · FY2004 · HL
REGULATION OF IMMUNITY BY PROSTAGLANDINS$318,642
R01 · FY2002 · DE
REGULATION OF IMMUNITY BY PROSTAGLANDINS$309,363
R01 · FY2001 · DE
REGULATION OF IMMUNITY BY PROSTAGLANDINS$300,353
R01 · FY2000 · DE
CD40 AND LUNG INFLAMMATION AND FIBROSIS$228,801
R01 · FY2000 · HL
ROLE OF FIBROBLAST SUBSETS AND CYTOKINES IN PULMONARY FIBROSIS$88,016
P30 · FY2000 · ES